MaryAnne Golling

MaryAnne M. Golling serves as a Contracting Officer and Team Leader responsible for managing complex acquisitions in scientific, technical, and healthcare-related domains. In this role, she leads the end-to-end procurement lifecycle—from market research and solicitation development to contract award and administration—ensuring compliance with federal regulations and mission-aligned outcomes. Her portfolio centers on high-value, technically demanding services and specialized manufacturing, supporting critical public health and research initiatives. As a team leader, she mentors junior contracting staff and coordinates with technical evaluators, legal counsel, and program managers to align acquisition strategy with agency objectives. Golling cultivates collaborative relationships with a diverse range of vendors, including established scientific consulting firms, biomedical manufacturers, and research institutions. While no single contractor dominates her portfolio, she consistently engages firms with demonstrated expertise in laboratory services, diagnostic development, and clinical support systems. Her procurement approach emphasizes competitive bidding, performance-based contracting, and rigorous source selection criteria to ensure technical excellence and accountability. Her contracting patterns reflect a strong preference for unrestricted, open competition, with 100% of her awards issued under no set-aside classifications. This indicates a focus on technical capability and value over socioeconomic preferences, though she remains fully compliant with all small business programs and may consider qualified small businesses when they meet stringent technical requirements. Golling’s primary procurement focus lies in NAICS 541690 (other scientific and technical consulting services) and 541712 (research and development in physical, engineering, and life sciences), reflecting her deep engagement with R&D-driven projects. She also frequently procures products and services under 325411 and 325413, specializing in medicinal manufacturing and in-vitro diagnostic substances, as well as 622110 for hospital-based operational support. Her expertise spans the intersection of regulatory compliance, clinical innovation, and advanced scientific procurement.